Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
TECH
vs
S&P 500
TECH
S&P 500
Over the past 12 months, TECH has outperformed S&P 500, delivering a return of +24% compared to S&P 500's +13% growth.
Stocks Performance
TECH vs S&P 500
Performance Gap
TECH vs S&P 500
Create a free account · No card needed
Performance By Year
TECH vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bio-Techne Corp
Glance View
Bio-Techne makes the tools scientists use to study cells and disease. Its products include antibodies, proteins, assays, cell and gene therapy reagents, and instruments used in life-science research and clinical testing. The company also sells diagnostic products that help labs detect and monitor certain medical conditions. Its main customers are drug developers, academic and government research labs, biotech companies, and clinical laboratories. Bio-Techne makes money by selling these consumable products, along with instruments and related services, through direct sales and distributors. Because many of its products are used repeatedly in research and testing workflows, it plays a steady supplier role in the life-science supply chain. What makes Bio-Techne different is that it sits close to the basic science stage of medicine. Instead of making finished drugs, it sells the specialized materials and testing tools that other companies and labs need to discover, develop, and validate those drugs and diagnostics. That gives it exposure to a wide range of research and healthcare end markets.
Create a free account · No card needed